Ensuring Leadership Continuity—The Coleman Health Services Case Study is starting in

How Do States Monitor Atypical Antipsychotics Prescribed To Children?: An OPEN MINDS Market Intelligence Report

Antipsychotic drugs were developed to specifically treat psychiatric disorders in the adult population. Over time the drugs have been increasingly prescribed to children as young as age three. Although some antipsychotics have been approved by the Federal Drug Administration (FDA) for use in children, there are very few long-term studies that show the efficacy and safety of these drugs for this age group. This has caused many concerns about prescribing antipsychotics to children, including the side effects, utilization patterns, and off-label prescribing.

Antipsychotic medications are part of the psychotropic drug class which also includes: stimulants (most commonly used . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.